LRAT is significantly overexpressed in colorectal cancer and significantly associated with prognosis.
| Inventor | Institute |
|---|---|
| Ayham Alnabulsi | Vertebrate Antibodies Limited |
| SKU: | 151869 |
|---|---|
| Product description: | LRAT is significantly overexpressed in colorectal cancer and significantly associated with prognosis. |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Immunogen: | Peptide Sequence – RDQRSVLASA (amino acids 190 -199) |
| Cat. #: | 151869 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Cancer types: | Colorectal cancer |
| Research Fields: | Cell signaling and signal transduction;Metabolism;Neurobiology |
| Application: | ELISA ; IHC ; IF ; WB |
| Target: | Lecithin Retinol Acyltransferase (LRAT) |
| Reactivity: | Human |
| Clone: | M34-P1F10 |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | LRAT is significantly overexpressed in colorectal cancer and significantly associated with prognosis. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Brown et al. 2014. PLoS One. 9(3):e90776. PMID: 24608339. The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancer. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151019 | Anti-Mos [S3.1] |
Key Info
Anti-Mos [S3.1]
|
View Tool | |||||||||||||||||||
| 151024 | Anti-Hairy [1/24] |
Key Info
Anti-Hairy [1/24]
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.